c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
BLSM
BlossomHill Therapeutics, Inc. Common Stock
stock
NASDAQ
Market Open
Nov 19, 2026 9:30:00 AM EST
15.07
USD
+3.467%
(+0.51)
880
Pre-market
After-hours
11.89
Bid
18.81
Ask
6.92
Spread
Overview
Company
Exchanges
Shorts
News
News
BLSM News
1
/
1
Sep 28, 2026
Day breaks
Nov 13, 2026
04:59 AM EST
BlossomHill Therapeutics (BLSM) Reports Improved Q3 EPS Amid Rising Net Loss
·
GuruFocus
04:44 AM EST
BlossomHill Therapeutics, Inc. reports Q3 results
·
Seeking Alpha
Nov 12, 2026
04:01 PM EST
BlossomHill Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
·
GlobeNewswire Inc.
Oct 29, 2026
03:12 PM EDT
Russell 2000 estimated to add 107 stocks in December rebalance - Stephens
·
Seeking Alpha
Oct 22, 2026
07:00 AM EDT
BlossomHill Therapeutics Announces Collaboration with Foundation Medicine to Develop First Companion Diagnostic for BH-30643 in EGFR C797S Mutated Non-Small Cell Lung Cancer
·
GlobeNewswire Inc.
Sep 28, 2026
07:00 AM EDT
BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer
·
GlobeNewswire Inc.
Sep 21, 2026
07:26 AM EDT
Guggenheim raises BlossomHill Therapeutics price target to $40 on pipeline progress
·
Investing.com